What is the current Anti-inflammatory Therapy market size?

The Anti-inflammatory Therapy market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Anti-inflammatory Therapy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Anti-inflammatory Therapy market?

Key drivers include rising prevalence of chronic diseases and growing awareness of anti-inflammatory therapies.

What are the major challenges facing the Anti-inflammatory Therapy market?

Major challenges include high development costs and stringent regulatory requirements.

Which regions are expected to lead the Anti-inflammatory Therapy market?

North America and Europe are expected to dominate the market due to high healthcare expenditure.

Who are the top companies in the Anti-inflammatory Therapy market?

Top companies include Pfizer, Johnson & Johnson, and GlaxoSmithKline, driving innovation and growth.

What future opportunities exist in the Anti-inflammatory Therapy market?

Future opportunities include emerging markets and increasing adoption of personalized medicine.

How is technology impacting the Anti-inflammatory Therapy market?

Technology is advancing diagnosis and treatment options, improving patient outcomes and future outlook.

What is the current regulatory landscape for the Anti-inflammatory Therapy market?

The regulatory landscape is evolving, with a focus on safety and efficacy, shaping the market's future outlook.

Anti-inflammatory Therapy - Strategic Insights: Analysis 2025 and Forecasts 2033

Anti-inflammatory Therapy by Application (Respiratory Diseases, Arthritis, Gastroenterology, Dermatology, Others), by Types (Corticosteroids, Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Anti-inflammatory Therapy Market Overview

The Anti-inflammatory Therapy market refers to the global marketplace for treatments and medications aimed at reducing inflammation in the body. As a crucial aspect of healthcare, the Anti-inflammatory Therapy market size is estimated to be around $120 billion. The growth outlook for this market is promising, with a market forecast that indicates a steady increase in demand for effective anti-inflammatory therapies. The industry expansion is driven by factors such as an aging population, an increase in chronic diseases, and advancements in medical technology. The scope of this market encompasses various types of anti-inflammatory therapies, including non-steroidal anti-inflammatory drugs (NSAIDs), biologics, and corticosteroids, catering to diverse applications and end-users.

Loading chart…

The current market is expected to witness a compound annual growth rate (CAGR) of around 5-7% during the forecast period, driven by macro drivers such as technological advancements, regulatory approvals, and changing consumer behavior. Key forces shaping the industry include technology shifts towards more targeted and effective therapies, regulations that promote the development of innovative treatments, and competitive intensity that fosters collaboration and innovation among market players. The largest region in the Anti-inflammatory Therapy market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by increasing healthcare expenditure and a growing patient pool.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	20.93 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AbbVie; Johnson & Johnson; Amgen Inc; AstraZeneca PLC; Pfizer, Inc.; Novartis; Roche; Merck; Sanofi; GlaxoSmithKline; Sun Pharmaceutical Industries Ltd; TEVA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Anti-inflammatory Therapy market is poised for significant growth, driven by factors such as increasing prevalence of chronic diseases and rising demand for effective treatments. The Anti-inflammatory Therapy market size is expected to expand substantially, with a growth forecast that underscores the potential for innovation and investment in this sector.

Growth Drivers2 items

Advances in biotechnology and pharmacology are enabling the development of novel Anti-inflammatory Therapy solutions, which are more targeted and have fewer side effects, driving growth in the Anti-inflammatory Therapy market

Government initiatives and funding for research in inflammation and immune response are providing a boost to the Anti-inflammatory Therapy market size, as new discoveries and treatments emerge

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the Anti-inflammatory Therapy market, which can restrain growth and impact the growth forecast

The risk of side effects and complications associated with certain Anti-inflammatory Therapy treatments is a concern, which can affect market adoption and the overall Anti-inflammatory Therapy market size

Opportunities2 items

The increasing focus on personalized medicine and targeted therapies presents opportunities for growth in the Anti-inflammatory Therapy market, as treatments can be tailored to individual patient needs

The rising demand for Anti-inflammatory Therapy in emerging markets, driven by growing healthcare infrastructure and expanding patient populations, is expected to contribute to the growth forecast of the Anti-inflammatory Therapy market

Challenges2 items

The complexity of inflammation biology and the need for more research in this area pose significant challenges for the development of effective Anti-inflammatory Therapy solutions, which can impact the Anti-inflammatory Therapy market size

The patent cliffs of key Anti-inflammatory Therapy products are approaching, which may lead to increased competition from generics and biosimilars, affecting the growth forecast and market dynamics

Market Segmentation

Loading chart…

The Application segment of the Anti-inflammatory Therapy market refers to the various uses of anti-inflammatory therapies across different medical conditions. This segment is crucial in understanding the Anti-inflammatory Therapy segmentation, as it highlights the diverse applications of these therapies, ranging from rheumatoid arthritis to asthma. The application segment is further divided into subtypes, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and asthma, among others. Each subtype has its unique characteristics, treatment options, and market size, contributing to the overall Anti-inflammatory Therapy market size.

The Types segment of the Anti-inflammatory Therapy market encompasses various categories of anti-inflammatory therapies, including corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), biologics, and small molecule therapies. This segment is vital in understanding the market taxonomy of Anti-inflammatory Therapy, as it provides insights into the different mechanisms of action, efficacy, and safety profiles of each type. The types segment is also divided into subtypes, such as oral corticosteroids, injected corticosteroids, systemic NSAIDs, and topical NSAIDs. Each subtype has its own market share, growth rate, and competitive landscape, influencing the overall Anti-inflammatory Therapy market size.

Anti-inflammatory Therapy Segmentation Breakdown11 items

Application

Respiratory Diseases

Arthritis

Gastroenterology

Dermatology

Others

Types

Corticosteroids

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs

Others

Regional Insights

Loading chart…

The Anti-inflammatory Therapy market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of anti-inflammatory therapies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - demographics, ecosystem maturity, and infrastructure; Europe - policies, adoption, and investments; Asia Pacific - demographics, infrastructure, and investments; Latin America - adoption, policies, and ecosystem maturity; and Middle East & Africa - infrastructure, investments, and demographics. These factors will influence the regional forecast and contribute to the overall Anti-inflammatory Therapy market growth.

The regional analysis highlights the importance of understanding the unique characteristics of each region, including regional forecast trends, to capitalize on opportunities and address challenges in the Anti-inflammatory Therapy market. By examining the interplay between adoption, policies, investments, demographics, infrastructure, and ecosystem maturity, stakeholders can develop effective strategies to drive growth and improve patient outcomes.

Competitive Landscape

The Anti-inflammatory Therapy market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Anti-inflammatory Therapy competitive landscape is driven by global players, but local companies are also gaining traction. Key competitive levers include pricing strategies, distribution networks, and product innovation, with companies seeking to differentiate themselves through certifications and regulatory approvals.

Companies in the Anti-inflammatory Therapy market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service models, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies are focusing on strategic initiatives such as:

AbbVie: regional expansion

Johnson & Johnson: innovation pipeline

Amgen Inc: premium pricing

AstraZeneca PLC: vertical integration

Pfizer, Inc.: OEM tie-ups

Novartis: local manufacturing

Key Anti-inflammatory Therapy Companies12 items

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc.

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Market Ecosystem

The Anti-inflammatory Therapy ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of anti-inflammatory therapies. The ecosystem boundaries are defined by the interactions between these segments, influencing how value is created and delivered to end users.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce anti-inflammatory therapies

Technology providers — develop new formulations and delivery systems

Distributors / channel partners — facilitate therapy distribution to healthcare providers

Service providers / after-sales — offer patient support and education services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — oversee therapy approvals and compliance

In the Anti-inflammatory Therapy ecosystem, control points are primarily held by regulators and end users, as they influence adoption and demand for therapies. Dependency risks arise from input constraints, such as raw material shortages, and standards approvals, which can impact the availability of therapies. Switching costs and partnerships between manufacturers and distributors can also affect the ecosystem. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and healthcare infrastructure, highlighting the need for a comprehensive value chain analysis to navigate these complexities.

Recent Industry Insights

The Anti-inflammatory Therapy industry has witnessed significant developments over the last 12-18 months, shaping Anti-inflammatory Therapy industry trends. Notable partnerships have been formed, such as collaborations between pharmaceutical companies and research institutions to develop innovative treatments. Additionally, there have been several mergers and acquisitions, allowing companies to expand their product portfolios and strengthen their market presence. Recent product launches have also been observed, with a focus on targeted therapies and biologics.

Furthermore, regulatory changes have influenced the industry, with updates to guidelines and protocols for clinical trials and drug approvals. A shift in consumer trends has also been observed, with a growing demand for personalized and sustainable treatment options. Funding rounds and expansions have been announced, providing companies with the necessary resources to advance their research and development efforts, ultimately driving growth in the Anti-inflammatory Therapy market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Anti-inflammatory Therapy market. The market attractiveness is driven by an increasing prevalence of chronic inflammatory diseases, making the Anti-inflammatory Therapy market outlook highly promising. The competitive intensity is moderate, with key players focusing on innovative treatments and strategic partnerships.

The long-term outlook for this market is favorable, with the innovation landscape expected to shift towards more targeted and personalized therapies. However, the demand–supply balance may be affected by regulatory challenges and key risk factors such as patent expirations and increasing competition from biosimilars.

11 items

1. Executive Summary

2. Anti-inflammatory Therapy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Anti-inflammatory Therapy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Anti-inflammatory Therapy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Respiratory Diseases

6.1.2. Arthritis

6.1.3. Gastroenterology

6.1.4. Dermatology

6.1.5. Others

6.2. Global Anti-inflammatory Therapy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Corticosteroids

6.2.2. Anti-inflammatory Biologics

6.2.3. Non-Steroidal Anti-inflammatory Drugs

6.2.4. Others

6.3. Global Anti-inflammatory Therapy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Anti-inflammatory Therapy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Anti-inflammatory Therapy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Anti-inflammatory Therapy Market Competition by Key Manufacturers

8.1. Global Anti-inflammatory Therapy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Anti-inflammatory Therapy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AbbVie

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Johnson & Johnson

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Amgen Inc

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. AstraZeneca PLC

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Pfizer, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Novartis

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Roche

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Merck

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sanofi

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. GlaxoSmithKline

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Sun Pharmaceutical Industries Ltd

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. TEVA

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Anti-inflammatory Therapy Market

Figure 4: Global Anti-inflammatory Therapy Market: Drivers

Figure 5: Global Anti-inflammatory Therapy Market: Challenges

Figure 6: Global Anti-inflammatory Therapy Market: Trends

Figure 7: Global Anti-inflammatory Therapy Market: Opportunity

Figure 8: Global Anti-inflammatory Therapy Market: Restraint

Figure 9: Global Anti-inflammatory Therapy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Anti-inflammatory Therapy Market Value (USD Million) By Region

Figure 15: Global Anti-inflammatory Therapy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Anti-inflammatory Therapy Market Value (USD Million) By Region

Figure 23: Global Anti-inflammatory Therapy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Anti-inflammatory Therapy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Anti-inflammatory Therapy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Anti-inflammatory Therapy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Anti-inflammatory Therapy Market Value (USD Million) By Region

Table 10: Global Anti-inflammatory Therapy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Anti-inflammatory Therapy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Anti-inflammatory Therapy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Anti-inflammatory Therapy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AbbVie Basic Information And Sales Area

Table 31: AbbVie. Products Portfolio

Table 32: Johnson & Johnson Basic Information And Sales Area

Table 33: Johnson & Johnson. Products Portfolio

Table 34: Amgen Inc Basic Information And Sales Area

Table 35: Amgen Inc. Products Portfolio

Table 36: AstraZeneca PLC Basic Information And Sales Area

Table 37: AstraZeneca PLC. Products Portfolio

Table 38: Pfizer, Inc. Basic Information And Sales Area

Table 39: Pfizer, Inc.. Products Portfolio

Table 40: Novartis Basic Information And Sales Area

Table 41: Novartis. Products Portfolio

Table 42: Roche Basic Information And Sales Area

Table 43: Roche. Products Portfolio

Table 44: Merck Basic Information And Sales Area

Table 45: Merck. Products Portfolio

Table 46: Sanofi Basic Information And Sales Area

Table 47: Sanofi. Products Portfolio

Table 48: GlaxoSmithKline Basic Information And Sales Area

Table 49: GlaxoSmithKline. Products Portfolio

Table 50: Sun Pharmaceutical Industries Ltd Basic Information And Sales Area

Table 51: Sun Pharmaceutical Industries Ltd. Products Portfolio

Table 52: TEVA Basic Information And Sales Area

Table 53: TEVA. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Anti-inflammatory Therapy Market Value (USD Million) By Region

Table 59: Global Anti-inflammatory Therapy Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Anti-inflammatory Therapy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	20.93 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AbbVie; Johnson & Johnson; Amgen Inc; AstraZeneca PLC; Pfizer, Inc.; Novartis; Roche; Merck; Sanofi; GlaxoSmithKline; Sun Pharmaceutical Industries Ltd; TEVA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Government initiatives and funding for research in inflammation and immune response are providing a boost to the Anti-inflammatory Therapy market size, as new discoveries and treatments emerge

Restraints2 items

High development costs and stringent regulatory requirements are limiting the entry of new players in the Anti-inflammatory Therapy market, which can restrain growth and impact the growth forecast

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Anti-inflammatory Therapy Segmentation Breakdown11 items

Application

Respiratory Diseases

Arthritis

Gastroenterology

Dermatology

Others

Types

Corticosteroids

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs

Others

Regional Insights

Loading chart…

Competitive Landscape

AbbVie: regional expansion

Johnson & Johnson: innovation pipeline

Amgen Inc: premium pricing

AstraZeneca PLC: vertical integration

Pfizer, Inc.: OEM tie-ups

Novartis: local manufacturing

Key Anti-inflammatory Therapy Companies12 items

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc.

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Market Ecosystem

Raw material suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce anti-inflammatory therapies

Technology providers — develop new formulations and delivery systems

Distributors / channel partners — facilitate therapy distribution to healthcare providers

Service providers / after-sales — offer patient support and education services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — oversee therapy approvals and compliance

Recent Industry Insights

Analyst Overview

Table of Contents